Τόμος 31 (2017) – Τεύχος 3 –Άρθρο 1 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 31 (2017) – Issue 3 – Article 1 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

By | | Πλήρες Κείμενο στα Αγγλικά - Full Text in English
Τίτλος – Title

Metabolic Syndrome and Olive Oil
Συγγραφέας – Author

Dr. I.Grech MSc., PhD. Dr1

1 Assoc. Professor of the department of Aesthetics and Cosmetology,

School of Professions of Health and Welfare, Technological Education Institution of Athens, Egaleo, Athens, Hellas
Παραπομπή – Citation

Dr. I.Grech. Metabolic Syndrome and Olive Oil.  Review Clin. Pharmacol. Pharmacokinet. 2017, 31, 3, 135-141
Ημερομηνία Δημοσιευσης – Publication Date
2017
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Αγγλικά – English
Λέξεις κλειδιά – Keywords

Metabolic syndrome, olive oil, type 2 diabetes, cardiovascular disease, insulin, obesity
Λοιποί Όροι – Other Terms

Μελέτη
Analysis
Περίληψη – Summary
 Metabolic syndrome (MetSyn) is a common multidimensional pathological condition defined by several genetic and environmental factors in all cases of biochemical, clinical and metabolic levels. These interconnected factors together increase the risk of cardiovascular disease (CDV) and type 2 diabetes mellitus (T2DM), but until now little is known for genetic contribution. The fact that metabolic syndrome is involved in many diseases shows that there is an interaction between clinical and biological phenotype hallmarks, namely atherogenic dyslipidemia, blood pressure and insulin resistance. Olive oil and its constituents have been revealed to be beneficial as therapeutic strategies against metabolic syndrome. In this review, we will focus on their effects on metabolic syndrome.
Αναφορές – References
  1. Camargo A, Ruano J, Fernandez JM, Parnell LD, Jimenez A, Santos-Gonzalez M, et al. Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC genomics. 2010;11:253.
  2. Phillips C, Lopez-Miranda J, Perez-Jimenez F, McManus R, Roche HM. Genetic and nutrient determinants of the metabolic syndrome. Current opinion in cardiology. 2006;21(3):185-93.
  3. Waterman E, Lockwood B. Active components and clinical applications of olive oil. Alternative medicine review : a journal of clinical therapeutic. 2007;12(4):331-42.
  4. Lusis AJ, Attie AD, Reue K. Metabolic syndrome: from epidemiology to systems biology. Nature reviews Genetics. 2008;9(11):819-30.
  5. Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. International journal of medical sciences. 2016;13(1):25-38.
  6. Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014:943162.
  7. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinology and metabolism clinics of North America. 2008;37(3):753-68, x-xi.
  8. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of lipid research. 2005;46(11):2347-55.
  9. Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH, Jr., et al. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. The Journal of clinical endocrinology and metabolism. 2009;94(7):2558-64.
  10. Tsimikas S, Willeit J, Knoflach M, Mayr M, Egger G, Notdurfter M, et al. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study. European heart journal. 2009;30(1):107-15.
  11. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, et al. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. European journal of clinical investigation. 2009;39(6):437-44.
  12. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocrine reviews. 2008;29(7):777-822.
  13. Brown L, Poudyal H, Panchal SK. Functional foods as potential therapeutic options for metabolic syndrome. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2015;16(11):914-41.
  14. Panchal SK, Brown L. Rodent models for metabolic syndrome research. Journal of biomedicine & biotechnology. 2011;2011:351982.
  15. Zuniga LY, Gonzalez-Ortiz M, Martinez-Abundis E. Effect of Gymnema sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. Journal of medicinal food. 2017.
  16. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Annals of internal medicine. 2006;145(1):1-11.
  17. Babio N, Toledo E, Estruch R, Ros E, Martinez-Gonzalez MA, Castaner O, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2014;186(17):E649-57.
  18. Ebrahimof S, Mirmiran P. Nutritional Approaches for Prevantion and Treatment of Metabolic Syndrome in Adults. Journal of Paramedical Sciences (JPS). 2013;4(2):12.
  19. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486-97.
  20. Cicerale S, Conlan XA, Sinclair AJ, Keast RS. Chemistry and health of olive oil phenolics. Critical reviews in food science and nutrition. 2009;49(3):218-36.
  21. Visioli F, Poli A, Gall C. Antioxidant and other biological activities of phenols from olives and olive oil. Medicinal research reviews. 2002;22(1):65-75.
  22. Owen RW, Giacosa A, Hull WE, Haubner R, Wurtele G, Spiegelhalder B, et al. Olive-oil consumption and health: the possible role of antioxidants. The Lancet Oncology. 2000;1:107-12.
  23. Perona JS, Cabello-Moruno R, Ruiz-Gutierrez V. The role of virgin olive oil components in the modulation of endothelial function. The Journal of nutritional biochemistry. 2006;17(7):429-45.
  24. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. The Journal of clinical endocrinology and metabolism. 2006;91(2):439-46.
  25. Fito M, Cladellas M, de la Torre R, Marti J, Alcantara M, Pujadas-Bastardes M, et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis. 2005;181(1):149-58.
  26. Berrougui H, Cloutier M, Isabelle M, Khalil A. Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis. 2006;184(2):389-96.
  27. Salvini S, Sera F, Caruso D, Giovannelli L, Visioli F, Saieva C, et al. Daily consumption of a high-phenol extra-virgin olive oil reduces oxidative DNA damage in postmenopausal women. The British journal of nutrition. 2006;95(4):742-51.
  28. Machowetz A, Poulsen HE, Gruendel S, Weimann A, Fito M, Marrugat J, et al. Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2007;21(1):45-52.
  29. Chrysohoou C, Pitsavos C, Skoumas J, Masoura C, Katinioti A, Panagiotakos D, et al. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. International journal of cardiology. 2007;122(1):29-33.
  30. Covas MI, Nyyssonen K, Poulsen HE, Kaikkonen J, Zunft HJ, Kiesewetter H, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Annals of internal medicine. 2006;145(5):333-41.
  31. Gorinstein S, Leontowicz H, Lojek A, Leontowicz M, Ciz M, Krzeminski R, et al. Olive oils improve lipid metabolism and increase antioxidant potential in rats fed diets containing cholesterol. Journal of agricultural and food chemistry. 2002;50(21):6102-8.
  32. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Annals of oncology : official journal of the European Society for Medical Oncology. 2005;16(3):359-71.
  33. Newmark HL. Squalene, olive oil, and cancer risk: a review and hypothesis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1997;6(12):1101-3.
  34. Stefanon B, Colitti M. Original Research: Hydroxytyrosol, an ingredient of olive oil, reduces triglyceride accumulation and promotes lipolysis in human primary visceral adipocytes during differentiation. Experimental biology and medicine. 2016;241(16):1796-802.
  35. Cao K, Xu J, Zou X, Li Y, Chen C, Zheng A, et al. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free radical biology & medicine. 2014;67:396-407.
  36. Poudyal H, Lemonakis N, Efentakis P, Gikas E, Halabalaki M, Andreadou I, et al. Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation. Pharmacological research. 2017;117:32-45.
  37. Lemonakis N, Poudyal H, Halabalaki M, Brown L, Tsarbopoulos A, Skaltsounis AL, et al. The LC-MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2017;1041-1042:45-59.
  38. Perez-Jimenez A, Rufino-Palomares EE, Fernandez-Gallego N, Ortuno-Costela MC, Reyes-Zurita FJ, Peragon J, et al. Target molecules in 3T3-L1 adipocytes differentiation are regulated by maslinic acid, a natural triterpene from Olea europaea. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2016;23(12):1301-11.
  39. Liu Y, Xu X, Bi D, Wang X, Zhang X, Dai H, et al. Influence of squalene feeding on plasma leptin, testosterone & blood pressure in rats. The Indian journal of medical research. 2009;129(2):150-3.
  40. de Melo CL, Queiroz MG, Fonseca SG, Bizerra AM, Lemos TL, Melo TS, et al. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet. Chemico-biological interactions. 2010;185(1):59-65.
  1. Ebaid GM, Seiva FR, Rocha KK, Souza GA, Novelli EL. Effects of olive oil and its minor phenolic constituents on obesity-induced cardiac metabolic changes. Nutrition journal. 2010;9:46.
  2. Parkinson L, Keast R. Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease. International journal of molecular sciences. 2014;15(7):12323-34.
  3. Montserrat-de la Paz S, Naranjo MC, Lopez S, Abia R, Muriana FJ, Bermudez B. Niacin and olive oil promote skewing to the M2 phenotype in bone marrow-derived macrophages of mice with metabolic syndrome. Food & function. 2016;7(5):2233-8.
  4. Naranjo MC, Bermudez B, Garcia I, Lopez S, Abia R, Muriana FJG, et al. Dietary fatty acids on aortic root calcification in mice with metabolic syndrome. Food & function. 2017;8(4):1468-74.
  5. Montserrat-de la Paz S, Bermudez B, Cardelo MP, Lopez S, Abia R, Muriana FJ. Olive oil and postprandial hyperlipidemia: implications for atherosclerosis and metabolic syndrome. Food & function. 2016;7(12):4734-44.
  6. Mayneris-Perxachs J, Sala-Vila A, Chisaguano M, Castellote AI, Estruch R, Covas MI, et al. Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PloS one. 2014;9(3):e85202.
  7. Sureda A, Bibiloni MD, Martorell M, Buil-Cosiales P, Marti A, Pons A, et al. Mediterranean diets supplemented with virgin olive oil and nuts enhance plasmatic antioxidant capabilities and decrease xanthine oxidase activity in people with metabolic syndrome: The PREDIMED study. Molecular nutrition & food research. 2016;60(12):2654-64.
  8. Venturini D, Simao AN, Urbano MR, Dichi I. Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome. Nutrition. 2015;31(6):834-40.
  9. Verhoeven V, Van der Auwera A, Van Gaal L, Remmen R, Apers S, Stalpaert M, et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC complementary and alternative medicine. 2015;15:52
Σχετικές Εργασίες – Relative Papers

Online ISSN 1011-6583

 

Bookmark the permalink.

Comments are closed.